BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 2516397)

  • 1. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
    Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
    Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapy of varicella zoster virus infection in immunocompromised patients. A comparison of acyclovir and vidarabine.
    Shepp DH; Dandliker PS; Meyers JD
    Am J Med; 1988 Aug; 85(2A):96-8. PubMed ID: 3044102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment in chickenpox and herpes zoster.
    Huff JC
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):204-6. PubMed ID: 3339143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative trial of acyclovir and vidarabine in disseminated varicella-zoster virus infections in immunocompromised patients.
    Vildé JL; Bricaire F; Leport C; Renaudie M; Brun-Vézinet F
    J Med Virol; 1986 Oct; 20(2):127-34. PubMed ID: 3534140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
    Balfour HH; McMonigal KA; Bean B
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic approaches to varicella-zoster virus infections.
    Whitley RJ
    J Infect Dis; 1992 Aug; 166 Suppl 1():S51-7. PubMed ID: 1378081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of varicella-zoster virus infection in severely immunocompromised patients. A randomized comparison of acyclovir and vidarabine.
    Shepp DH; Dandliker PS; Meyers JD
    N Engl J Med; 1986 Jan; 314(4):208-12. PubMed ID: 3001523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and treatment of varicella-zoster in high-risk populations.
    Gnann JW; Whitley RJ
    J Hosp Infect; 1991 Jun; 18 Suppl A():317-29. PubMed ID: 1679798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
    Balfour HH
    Am J Med; 1988 Aug; 85(2A):68-73. PubMed ID: 3044096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy for varicella and herpes zoster.
    Arvin AM
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):12-21. PubMed ID: 12118839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early relapses of varicella-zoster virus infection in immunocompromised children treated with acyclovir.
    Mészner Z; Gyarmati E; Nyerges G; Simon M; Koller M
    Acta Paediatr Hung; 1990; 30(2):263-70. PubMed ID: 2248805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of acyclovir treatment of chickenpox and herpes zoster in children with immune tolerance].
    Jankowska H; Szczepańska-Putz M; Wojnarowski M
    Pol Tyg Lek; 1989 Aug 21-28; 44(34-35):799-800. PubMed ID: 2485894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS.
    Pahwa S; Biron K; Lim W; Swenson P; Kaplan MH; Sadick N; Pahwa R
    JAMA; 1988 Nov; 260(19):2879-82. PubMed ID: 3184352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
    Whitley RJ; Gnann JW; Hinthorn D; Liu C; Pollard RB; Hayden F; Mertz GJ; Oxman M; Soong SJ
    J Infect Dis; 1992 Mar; 165(3):450-5. PubMed ID: 1538151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS).
    Jacobson MA; Berger TG; Fikrig S; Becherer P; Moohr JW; Stanat SC; Biron KK
    Ann Intern Med; 1990 Feb; 112(3):187-91. PubMed ID: 2297195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression.
    Leuvenink R; Aeschlimann F; Baer W; Berthet G; Cannizzaro E; Hofer M; Kaiser D; Schroeder S; Heininger U; Woerner A
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):34. PubMed ID: 27256096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella and herpes zoster infections in immunocompromised host: prevention and treatment.
    Ramírez Palacios RM; Sánchez J; Bermúdez RH; Ramírez Ronda CH
    Bol Asoc Med P R; 1986 Apr; 78(4):142-5. PubMed ID: 2424477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.